Neville B, Damm D, Allen C, Bouquot J
Retatrutide is a triple-receptor agonist peptide studied in metabolic research for its simultaneous activation of GLP-1, GIP, and glucagon receptors , making it the most advanced multi-pathway metabolic research compound currently available and representing the next generation beyond dual-receptor peptides like Tirzepatide and Semaglutide
The injection can be administered in the abdomen, thigh, or upper arm, and patients should rotate injection sites weekly to minimize local reactions such as redness, itching, or induration at the injection site
Available as a weekly injection (30-day supply $189$299, 90-day program $499$569) or as an oral tablet (OST, flat $199 any strength)
Similar side effects Both Zepbound and Mounjaro share a similar side effects profile due to their common active ingredient (Tirzepatide)
Wondering about the semaglutide cost with insurance